Blood cancers, Myeloma
Results
Phase 2
This trial looked at carfilzomib and the timing of a for people with myeloma.
It was for people with myeloma who had not had treatment.
Cancer Research UK supported this trial.
This trial was open for people to join between 2015 and 2019. The team published these results in 2022.
Recruitment start: 1 June 2015
Recruitment end: 8 May 2019
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Kwee Yong
Amgen
Cancer Research UK
University College London (UCL)
This is Cancer Research UK trial number CRUK/13/032.
Last reviewed: 22 May 2023
CRUK internal database number: 11766
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
